Dr. Jakub Woloszyn, MD

Dr. Woloszyn practices at Loma Linda University Medical Center in Loma Linda, California, part of Seventh-day Adventist Church.

Dr. Woloszyn's NPI, 1376839449, was assigned on June 27, 2011. Dr. Woloszyn graduated from UT Southwestern Medical Center in 2011. Dr. Woloszyn holds California license A124914.

Dr. Woloszyn's primary practice is Loma Linda University Medical Center, at 11234 Anderson St, Loma Linda, CA 92354 in San Bernardino County. The practice phone is (909) 558-4000.

Dr. Woloszyn's primary practice is Loma Linda University Medical Center in Loma Linda, California, part of Seventh-day Adventist Church. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Woloszyn to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Woloszyn practices, 2 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Woloszyn's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Woloszyn is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Woloszyn's licenses on file in 2 states: California and Georgia.

Dmand AI lists kidney transplant among the conditions Dr. Woloszyn treats.

CMS data shows 73 Medicare services from Dr. Woloszyn across 2 procedure codes in 2024, for 49 Medicare patients. Medicare paid $5,044 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 49 Medicare patients who saw Dr. Woloszyn in 2024. The largest group is under 65, with 35 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 78% are also on Medicaid. Their average risk score is 7.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Woloszyn's median patient age at 53, with 41% women.

In 2024, Dr. Woloszyn wrote 1,295 Medicare Part D claims for 123 patients. 86% of them were for generic drugs. CMS names the drug for 1,117 of them, across 24 drugs with 11 or more claims each, at $46,964 in total drug cost. In 2023, CMS named 1,772 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Woloszyn for performance year 2024, reported as part of a group. Dr. Woloszyn accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Woloszyn, published from 2009 to 2023. Dr. Woloszyn's most frequent co-authors are James Chin Becker, MD, Richard John Bold, MD and Michael J. Campbell, MD.

CMS Open Payments shows 66 general payments to Dr. Woloszyn from 22 drug and device companies from 2019 to 2025. Education make up the largest share, 39% of the total. Intuitive Surgical, Inc. paid the most, $6,396. It also lists 2 research payments totaling $203 in 2017.

Dmand AI lists 1 award for Dr. Woloszyn.

Dr. Woloszyn graduated from UT Southwestern Medical Center in 2011. Dr. Woloszyn is a member of ACS.

Dr. Woloszyn is in network with 17 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.